BIOMETHANIVELLES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOMETHANIVELLES
Largest movements
- Receivables within one year -€7,091
no longer reported in 2025 (was €7,091)
- Intangible fixed assets -€2,932
down €2,932 (-7.5%), from €39,139 to €36,207
- Cash +€636
up €636 (+32.0%), from €1,988 to €2,624
mainly Depreciation (+€12,192) and Receivables within one year (+€7,091)
- Profit (loss) carried forward -€14,729
down €14,729 (-64.1%), from -€22,971 to -€37,700
- Trade debts +€6,299
up €6,299 (+2,718%), from €232 to €6,531
- Tax, wage and social debts -€957
no longer reported in 2025 (was €957)
- Depreciation +€2,957
up €2,957 (+32.0%), from €9,235 to €12,192
- Gross operating margin -€808
down €808 (-47.9%), from -€1,686 to -€2,494
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,217 | €38,831 | -€9,386 | -19.5% |
| Fixed assets | 21/28 | €39,139 | €36,207 | -€2,932 | -7.5% |
| Intangible fixed assets | 21 | €39,139 | €36,207 | -€2,932 | -7.5% |
| Current assets | 29/58 | €9,078 | €2,624 | -€6,454 | -71.1% |
| Amounts receivable within one year | 40/41 | €7,091 | - | -€7,091 | |
| Trade receivables | 40 | €7,091 | - | -€7,091 | |
| Cash at bank and in hand | 54/58 | €1,988 | €2,624 | +€636 | +32.0% |
| Total equity and liabilities | 10/49 | €48,217 | €38,831 | -€9,386 | -19.5% |
| Equity | 10/15 | -€2,971 | -€17,700 | -€14,729 | -496% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€22,971 | -€37,700 | -€14,729 | -64.1% |
| Amounts payable | 17/49 | €51,188 | €56,531 | +€5,342 | +10.4% |
| Amounts payable within one year | 42/48 | €51,188 | €56,531 | +€5,342 | +10.4% |
| Trade debts | 44 | €232 | €6,531 | +€6,299 | +2,718% |
| Suppliers | 440/4 | €232 | €6,531 | +€6,299 | +2,718% |
| Taxes, remuneration and social security | 45 | €957 | - | -€957 | |
| Taxes | 450/3 | €957 | - | -€957 | |
| Other amounts payable | 47/48 | €50,000 | €50,000 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,235 | €12,192 | +€2,957 | +32.0% |
| Gross operating margin | 9900 | -€1,686 | -€2,494 | -€808 | -47.9% |
| Operating profit (loss) | 9901 | -€10,922 | -€14,687 | -€3,765 | -34.5% |
| Financial charges | 65/66B | €42 | €42 | = | 0.0% |
| Recurring financial charges | 65 | €42 | €42 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | -€10,964 | -€14,729 | -€3,765 | -34.3% |
| Profit (loss) for the period | 9904 | -€10,964 | -€14,729 | -€3,765 | -34.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,964 | -€14,729 | -€3,765 | -34.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.